Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Birth length and weight as predictors of breast cancer prognosis

Authors: Bjørn O Mæhle, Lars J Vatten, Steinar Tretli

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Birth size, and particularly birth length, is positively associated with breast cancer risk in adulthood. The objective of this study was to examine whether birth size is associated with survival among breast cancer patients.

Methods

Information on birth size (weight, length and ponderal index (kg/length (m3)) was collected from birth archives for 331 breast cancer patients who were diagnosed at two university hospitals in Norway (Bergen and Trondheim). The patients were followed from the time of diagnosis until death from breast cancer, death from another cause, or to the end of follow-up, and birth size was related to survival, using Cox regression analysis.

Results

Breast cancer patients with birth length ≥ 52 cm had nearly twice the risk of dying (hazard ratio, 1.92, 95% confidence interval, 1.09-3.41) from breast cancer compared to women with birth length less than 48 cm, after adjustment for place of birth and year of diagnosis.
Similar analyses related to birth weight and ponderal index showed no clear association with breast cancer survival.

Conclusions

Poorer outcome of breast cancer patients with high birth length may reflect effects of factors that stimulate longitudinal growth and simultaneously increase the risk of metastases and fatal outcome. It is possible that the insulin-like growth factor (IGF) system is involved in the underlying mechanisms.
Literature
1.
go back to reference McCormack VA, dos Santos Silva I, De Stavola BL, Mohsen R, Leon DA, Lithell HO: Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort. BMJ. 2003, 326 (7383): 248-10.1136/bmj.326.7383.248.CrossRefPubMedPubMedCentral McCormack VA, dos Santos Silva I, De Stavola BL, Mohsen R, Leon DA, Lithell HO: Fetal growth and subsequent risk of breast cancer: results from long term follow up of Swedish cohort. BMJ. 2003, 326 (7383): 248-10.1136/bmj.326.7383.248.CrossRefPubMedPubMedCentral
2.
go back to reference Grotmol T, Weiderpass E, Tretli S: Conditions in utero and cancer risk. Eur J Epidemiol. 2006, 21 (8): 561-570. 10.1007/s10654-006-9036-7.CrossRefPubMed Grotmol T, Weiderpass E, Tretli S: Conditions in utero and cancer risk. Eur J Epidemiol. 2006, 21 (8): 561-570. 10.1007/s10654-006-9036-7.CrossRefPubMed
3.
go back to reference Vatten LJ, Nilsen TI, Tretli S, Trichopoulos D, Romundstad PR: Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer. 2005, 114 (3): 461-464. 10.1002/ijc.20726.CrossRefPubMed Vatten LJ, Nilsen TI, Tretli S, Trichopoulos D, Romundstad PR: Size at birth and risk of breast cancer: prospective population-based study. Int J Cancer. 2005, 114 (3): 461-464. 10.1002/ijc.20726.CrossRefPubMed
4.
go back to reference Silva IS, de Stavola B, McCormack V: Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 2008, 5: 1372-86. 10.1371/journal.pmed.0050193.CrossRef Silva IS, de Stavola B, McCormack V: Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 2008, 5: 1372-86. 10.1371/journal.pmed.0050193.CrossRef
5.
go back to reference Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM: Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001, 23 (2): 313-342.CrossRefPubMed Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM: Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001, 23 (2): 313-342.CrossRefPubMed
6.
go back to reference Tretli S: Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer. 1989, 44 (1): 23-30. 10.1002/ijc.2910440105.CrossRefPubMed Tretli S: Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer. 1989, 44 (1): 23-30. 10.1002/ijc.2910440105.CrossRefPubMed
7.
go back to reference Brandt van den PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, et al: Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000, 152 (6): 514-527. 10.1093/aje/152.6.514.CrossRefPubMed Brandt van den PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, et al: Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000, 152 (6): 514-527. 10.1093/aje/152.6.514.CrossRefPubMed
8.
go back to reference Maehle BO, Tretli S, Thorsen T: The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS. 2004, 112 (6): 349-357. 10.1111/j.1600-0463.2004.apm1120605.x.CrossRefPubMed Maehle BO, Tretli S, Thorsen T: The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status. APMIS. 2004, 112 (6): 349-357. 10.1111/j.1600-0463.2004.apm1120605.x.CrossRefPubMed
9.
go back to reference Tretli S, Haldorsen T, Ottestad L: The effect of pre-morbid height and weight on the survival of breast cancer patients. Br J Cancer. 1990, 62 (2): 299-303.CrossRefPubMedPubMedCentral Tretli S, Haldorsen T, Ottestad L: The effect of pre-morbid height and weight on the survival of breast cancer patients. Br J Cancer. 1990, 62 (2): 299-303.CrossRefPubMedPubMedCentral
10.
go back to reference Magnusson PK, Rasmussen F, Gyllensten UB: Height at age 18 years is a strong predictor of attained education later in life: cohort study of over 950,000 Swedish men. Int J Epidemiol. 2006, 35 (3): 658-663. 10.1093/ije/dyl011.CrossRefPubMed Magnusson PK, Rasmussen F, Gyllensten UB: Height at age 18 years is a strong predictor of attained education later in life: cohort study of over 950,000 Swedish men. Int J Epidemiol. 2006, 35 (3): 658-663. 10.1093/ije/dyl011.CrossRefPubMed
11.
go back to reference Eide MG, Oyen N, Skjaerven R, Nilsen ST, Bjerkedal T, Tell GS: Size at birth and gestational age as predictors of adult height and weight. Epidemiology. 2005, 16 (2): 175-181. 10.1097/01.ede.0000152524.89074.bf.CrossRefPubMed Eide MG, Oyen N, Skjaerven R, Nilsen ST, Bjerkedal T, Tell GS: Size at birth and gestational age as predictors of adult height and weight. Epidemiology. 2005, 16 (2): 175-181. 10.1097/01.ede.0000152524.89074.bf.CrossRefPubMed
12.
go back to reference Sorensen HT, Sabroe S, Rothman KJ, Gillman M, Steffensen FH, Fischer P, Sorensen TI: Birth weight and length as predictors for adult height. Am J Epidemiol. 1999, 149 (8): 726-729.CrossRefPubMed Sorensen HT, Sabroe S, Rothman KJ, Gillman M, Steffensen FH, Fischer P, Sorensen TI: Birth weight and length as predictors for adult height. Am J Epidemiol. 1999, 149 (8): 726-729.CrossRefPubMed
Metadata
Title
Birth length and weight as predictors of breast cancer prognosis
Authors
Bjørn O Mæhle
Lars J Vatten
Steinar Tretli
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-115

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine